P2X7 receptor inhibition improves recovery after spinal cord injury
Author: ["Xiaohai Wang","Gregory Arcuino","Takahiro Takano","Jane Lin","Wei Guo Peng","Pinglan Wan","Pingjia Li","Qiwu Xu","Qing Song Liu","Steven A Goldman","Maiken Nedergaard"]
Publication: Nature Medicine
CITE.CC academic search helps you expand the influence of your papers.
Abstract
Secondary injury exacerbates the extent of spinal cord insults, yet the mechanistic basis of this phenomenon has largely been unexplored. Here we report that broad regions of the peritraumatic zone are characterized by a sustained process of pathologic, high ATP release. Spinal cord neurons expressed P2X7 purine receptors (P2X7R), and exposure to ATP led to high-frequency spiking, irreversible increases in cytosolic calcium and cell death. To assess the potential effect of P2X7R blockade in ameliorating acute spinal cord injury (SCI), we delivered P2X7R antagonists OxATP or PPADS to rats after acute impact injury. We found that both OxATP and PPADS significantly improved functional recovery and diminished cell death in the peritraumatic zone. These observations demonstrate that SCI is associated with prolonged purinergic receptor activation, which results in excitotoxicity-based neuronal degeneration. P2X7R antagonists inhibit this process, reducing both the histological extent and functional sequelae of acute SCI.
Cite this article
Wang, X., Arcuino, G., Takano, T. et al. P2X7 receptor inhibition improves recovery after spinal cord injury. Nat Med 10, 821–827 (2004). https://doi.org/10.1038/nm1082
